Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 145 to 156 of 156 entries
Sorted by: Best Match Show Resources per page
EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report.

RMD open

Bottai M, Tjärnlund A, Santoni G, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, García-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinka M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O'Callaghan A, Wook Song Y, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, Lundberg IE.
PMID: 29177080
RMD Open. 2017 Nov 14;3(2):e000507. doi: 10.1136/rmdopen-2017-000507. eCollection 2017.

OBJECTIVE: To describe the methodology used to develop new classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIMs) and their major subgroups.METHODS: An international, multidisciplinary group of myositis experts produced a set of 93 potentially relevant variables to...

Cite
Bottai M, Tjärnlund A, Santoni G, et al. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017;3(2):e000507doi: 10.1136/rmdopen-2017-000507.
Bottai, M., Tjärnlund, A., Santoni, G., Werth, V. P., Pilkington, C., de Visser, M., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., Singh, J. A., Aggarwal, R., Arnardottir, S., Chinoy, H., Cooper, R. G., Danko, K., Dimachkie, M. M., Feldman, B. M., García-De La Torre, I., Gordon, P., Hayashi, T., Katz, J. D., Kohsaka, H., Lachenbruch, P. A., Lang, B. A., Li, Y., Oddis, C. V., Olesinka, M., Reed, A. M., Rutkowska-Sak, L., Sanner, H., Selva-O'Callaghan, A., Wook Song, Y., Vencovsky, J., Ytterberg, S. R., Miller, F. W., Rider, L. G., Lundberg, I. E. (2017). EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD open, 3(2), e000507. https://doi.org/10.1136/rmdopen-2017-000507
Bottai, Matteo, et al. "EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report." RMD open vol. 3,2 (2017): e000507. doi: https://doi.org/10.1136/rmdopen-2017-000507
Bottai M, Tjärnlund A, Santoni G, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, García-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinka M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O'Callaghan A, Wook Song Y, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, Lundberg IE. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017 Nov 14;3(2):e000507. doi: 10.1136/rmdopen-2017-000507. eCollection 2017. PMID: 29177080; PMCID: PMC5687535.
Copy Download .nbib Format: NLM
The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future.

Frontiers in endocrinology

Chen YG, Mathews CE, Driver JP.
PMID: 29527189
Front Endocrinol (Lausanne). 2018 Feb 23;9:51. doi: 10.3389/fendo.2018.00051. eCollection 2018.

For more than 35 years, the NOD mouse has been the primary animal model for studying autoimmune diabetes. During this time, striking similarities to the human disease have been uncovered. In both species, unusual polymorphisms in a major histocompatibility...

Cite
Chen YG, Mathews CE, Driver JP. The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future. Front Endocrinol (Lausanne). 2018;9:51doi: 10.3389/fendo.2018.00051.
Chen, Y. G., Mathews, C. E., & Driver, J. P. (2018). The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future. Frontiers in endocrinology, 951. https://doi.org/10.3389/fendo.2018.00051
Chen, Yi-Guang, et al. "The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future." Frontiers in endocrinology vol. 9 (2018): 51. doi: https://doi.org/10.3389/fendo.2018.00051
Chen YG, Mathews CE, Driver JP. The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future. Front Endocrinol (Lausanne). 2018 Feb 23;9:51. doi: 10.3389/fendo.2018.00051. eCollection 2018. PMID: 29527189; PMCID: PMC5829040.
Copy Download .nbib Format: NLM
Sex Work and High-Risk Anal Human Papillomavirus Infection Among Transgender Women: The Condesa Study.

Transgender health

Portillo-Romero AJ, Allen-Leigh B, Nyitray AG, Carnalla M, Salmerón J, León-Maldonado L, Yunes E, Rivera L, Magis-Rodríguez C, Vargas G, Giuliano AR, Esquivel-Ocampo EA, Lazcano-Ponce E.
PMID: 34993304
Transgend Health. 2021 Dec 02;6(6):315-324. doi: 10.1089/trgh.2020.0075. eCollection 2021 Dec.

No abstract available.

Cite
Portillo-Romero AJ, Allen-Leigh B, Nyitray AG, et al. Sex Work and High-Risk Anal Human Papillomavirus Infection Among Transgender Women: The Condesa Study. Transgend Health. 2021;6(6):315-324doi: 10.1089/trgh.2020.0075.
Portillo-Romero, A. J., Allen-Leigh, B., Nyitray, A. G., Carnalla, M., Salmerón, J., León-Maldonado, L., Yunes, E., Rivera, L., Magis-Rodríguez, C., Vargas, G., Giuliano, A. R., Esquivel-Ocampo, E. A., & Lazcano-Ponce, E. (2021). Sex Work and High-Risk Anal Human Papillomavirus Infection Among Transgender Women: The Condesa Study. Transgender health, 6(6), 315-324. https://doi.org/10.1089/trgh.2020.0075
Portillo-Romero, Alejandra J, et al. "Sex Work and High-Risk Anal Human Papillomavirus Infection Among Transgender Women: The Condesa Study." Transgender health vol. 6,6 (2021): 315-324. doi: https://doi.org/10.1089/trgh.2020.0075
Portillo-Romero AJ, Allen-Leigh B, Nyitray AG, Carnalla M, Salmerón J, León-Maldonado L, Yunes E, Rivera L, Magis-Rodríguez C, Vargas G, Giuliano AR, Esquivel-Ocampo EA, Lazcano-Ponce E. Sex Work and High-Risk Anal Human Papillomavirus Infection Among Transgender Women: The Condesa Study. Transgend Health. 2021 Dec 02;6(6):315-324. doi: 10.1089/trgh.2020.0075. eCollection 2021 Dec. PMID: 34993304; PMCID: PMC8664109.
Copy Download .nbib Format: NLM
Anti-cortactin autoantibodies are associated with key clinical features in adult myositis but are rarely present in juvenile myositis.

Arthritis & rheumatology (Hoboken, N.J.)

Pinal-Fernandez I, Pak K, Gil-Vila A, Baucells A, Plotz B, Casal-Dominguez M, Derfoul A, Angeles Martinez M, Selva-O'Callaghan A, Sabbagh S, Casciola-Rosen L, Albayda J, Paik J, Tiniakou E, Danoff SK, Lloyd TE, Miller FW, Rider LG, Christopher-Stine L, Mammen AL.
PMID: 34313394
Arthritis Rheumatol. 2021 Jul 27; doi: 10.1002/art.41931. Epub 2021 Jul 27.

OBJECTIVE: To define the prevalence and clinical phenotype of anti-cortactin autoantibodies in adult and juvenile myositis.METHODS: In this longitudinal cohort study, anti-cortactin autoantibody titers were assessed by ELISA in 670 adults and 343 juvenile myositis patients as well as...

Cite
Pinal-Fernandez I, Pak K, Gil-Vila A, et al. Anti-cortactin autoantibodies are associated with key clinical features in adult myositis but are rarely present in juvenile myositis. Arthritis Rheumatol. 2021;doi: 10.1002/art.41931.
Pinal-Fernandez, I., Pak, K., Gil-Vila, A., Baucells, A., Plotz, B., Casal-Dominguez, M., Derfoul, A., Angeles Martinez, M., Selva-O'Callaghan, A., Sabbagh, S., Casciola-Rosen, L., Albayda, J., Paik, J., Tiniakou, E., Danoff, S. K., Lloyd, T. E., Miller, F. W., Rider, L. G., Christopher-Stine, L., Mammen, A. L. (2021). Anti-cortactin autoantibodies are associated with key clinical features in adult myositis but are rarely present in juvenile myositis. Arthritis & rheumatology (Hoboken, N.J.), . https://doi.org/10.1002/art.41931
Pinal-Fernandez, Iago, et al. "Anti-cortactin autoantibodies are associated with key clinical features in adult myositis but are rarely present in juvenile myositis." Arthritis & rheumatology (Hoboken, N.J.) vol. (2021). doi: https://doi.org/10.1002/art.41931
Pinal-Fernandez I, Pak K, Gil-Vila A, Baucells A, Plotz B, Casal-Dominguez M, Derfoul A, Angeles Martinez M, Selva-O'Callaghan A, Sabbagh S, Casciola-Rosen L, Albayda J, Paik J, Tiniakou E, Danoff SK, Lloyd TE, Miller FW, Rider LG, Christopher-Stine L, Mammen AL. Anti-cortactin autoantibodies are associated with key clinical features in adult myositis but are rarely present in juvenile myositis. Arthritis Rheumatol. 2021 Jul 27; doi: 10.1002/art.41931. Epub 2021 Jul 27. PMID: 34313394.
Copy Download .nbib Format: NLM
Association between frailty and self-reported health following heart valve surgery.

International journal of cardiology. Heart & vasculature

Borregaard B, Dahl JS, Lauck SB, Ryg J, Berg SK, Ekholm O, Hendriks JM, Riber LPS, Norekvål TM, Møller JE.
PMID: 33235899
Int J Cardiol Heart Vasc. 2020 Nov 13;31:100671. doi: 10.1016/j.ijcha.2020.100671. eCollection 2020 Dec.

BACKGROUND: Knowledge about the association between frailty and self-reported health among patients undergoing heart valve surgery remains sparse. Thus, the objectives were to I) describe changes in self-reported health at different time points according to frailty status, and to...

Cite
Borregaard B, Dahl JS, Lauck SB, et al. Association between frailty and self-reported health following heart valve surgery. Int J Cardiol Heart Vasc. 2020;31:100671doi: 10.1016/j.ijcha.2020.100671.
Borregaard, B., Dahl, J. S., Lauck, S. B., Ryg, J., Berg, S. K., Ekholm, O., Hendriks, J. M., Riber, L. P. S., Norekvål, T. M., & Møller, J. E. (2020). Association between frailty and self-reported health following heart valve surgery. International journal of cardiology. Heart & vasculature, 31100671. https://doi.org/10.1016/j.ijcha.2020.100671
Borregaard, Britt, et al. "Association between frailty and self-reported health following heart valve surgery." International journal of cardiology. Heart & vasculature vol. 31 (2020): 100671. doi: https://doi.org/10.1016/j.ijcha.2020.100671
Borregaard B, Dahl JS, Lauck SB, Ryg J, Berg SK, Ekholm O, Hendriks JM, Riber LPS, Norekvål TM, Møller JE. Association between frailty and self-reported health following heart valve surgery. Int J Cardiol Heart Vasc. 2020 Nov 13;31:100671. doi: 10.1016/j.ijcha.2020.100671. eCollection 2020 Dec. PMID: 33235899; PMCID: PMC7670239.
Copy Download .nbib Format: NLM
Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents two years after vaccination.

The Journal of infectious diseases

López-Medina E, Biswal S, Saez-Llorens X, Borja-Tabora C, Bravo L, Sirivichayakul C, Vargas LM, Alera MT, Velásquez H, Reynales H, Rivera L, Watanaveeradej V, Rodriguez-Arenales EJ, Yu D, Espinoza F, Dietze R, Fernando L, Wickramasinghe P, Duarte Moreira E, Fernando AD, Gunasekera D, Luz K, da Cunha RV, Tricou V, Rauscher M, Liu M, LeFevre I, Wallace D, Kosalaraksa P, Borkowski A.
PMID: 33319249
J Infect Dis. 2020 Dec 15; doi: 10.1093/infdis/jiaa761. Epub 2020 Dec 15.

BACKGROUND: Takeda's dengue vaccine is under evaluation in an ongoing Phase 3 efficacy study; we present an update after 2 years.METHODS: 20,099 children (4-16 years old) were randomized to receive two doses of TAK-003 or placebo three months apart...

Cite
López-Medina E, Biswal S, Saez-Llorens X, et al. Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents two years after vaccination. J Infect Dis. 2020;doi: 10.1093/infdis/jiaa761.
López-Medina, E., Biswal, S., Saez-Llorens, X., Borja-Tabora, C., Bravo, L., Sirivichayakul, C., Vargas, L. M., Alera, M. T., Velásquez, H., Reynales, H., Rivera, L., Watanaveeradej, V., Rodriguez-Arenales, E. J., Yu, D., Espinoza, F., Dietze, R., Fernando, L., Wickramasinghe, P., Duarte Moreira, E., Fernando, A. D., Gunasekera, D., Luz, K., da Cunha, R. V., Tricou, V., Rauscher, M., Liu, M., LeFevre, I., Wallace, D., Kosalaraksa, P., Borkowski, A. (2020). Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents two years after vaccination. The Journal of infectious diseases, . https://doi.org/10.1093/infdis/jiaa761
López-Medina, Eduardo, et al. "Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents two years after vaccination." The Journal of infectious diseases vol. (2020). doi: https://doi.org/10.1093/infdis/jiaa761
López-Medina E, Biswal S, Saez-Llorens X, Borja-Tabora C, Bravo L, Sirivichayakul C, Vargas LM, Alera MT, Velásquez H, Reynales H, Rivera L, Watanaveeradej V, Rodriguez-Arenales EJ, Yu D, Espinoza F, Dietze R, Fernando L, Wickramasinghe P, Duarte Moreira E, Fernando AD, Gunasekera D, Luz K, da Cunha RV, Tricou V, Rauscher M, Liu M, LeFevre I, Wallace D, Kosalaraksa P, Borkowski A. Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents two years after vaccination. J Infect Dis. 2020 Dec 15; doi: 10.1093/infdis/jiaa761. Epub 2020 Dec 15. PMID: 33319249.
Copy Download .nbib Format: NLM
Supporting Romantic Relationships During COVID-19 Using Virtual Couple Therapy.

Cognitive and behavioral practice

O'Reilly Treter M, River LM, Markman HJ.
PMID: 34629835
Cogn Behav Pract. 2021 Nov;28(4):597-607. doi: 10.1016/j.cbpra.2021.02.002. Epub 2021 Mar 29.

The novel coronavirus disease pandemic (COVID-19) has profoundly impacted people's lives, resulting in economic turmoil, death and suffering, and drastic changes to everyday life. The adjustment and strain of such challenges can spill over into couples' relationship processes, including...

Cite
O'Reilly Treter M, River LM, Markman HJ. Supporting Romantic Relationships During COVID-19 Using Virtual Couple Therapy. Cogn Behav Pract. 2021;28(4):597-607doi: 10.1016/j.cbpra.2021.02.002.
O'Reilly Treter, M., River, L. M., & Markman, H. J. (2021). Supporting Romantic Relationships During COVID-19 Using Virtual Couple Therapy. Cognitive and behavioral practice, 28(4), 597-607. https://doi.org/10.1016/j.cbpra.2021.02.002
O'Reilly Treter, Maggie, et al. "Supporting Romantic Relationships During COVID-19 Using Virtual Couple Therapy." Cognitive and behavioral practice vol. 28,4 (2021): 597-607. doi: https://doi.org/10.1016/j.cbpra.2021.02.002
O'Reilly Treter M, River LM, Markman HJ. Supporting Romantic Relationships During COVID-19 Using Virtual Couple Therapy. Cogn Behav Pract. 2021 Nov;28(4):597-607. doi: 10.1016/j.cbpra.2021.02.002. Epub 2021 Mar 29. PMID: 34629835; PMCID: PMC8488179.
Copy Download .nbib Format: NLM
Preliminary Validation of Muscle Ultrasound in Juvenile Dermatomyositis (JDM).

Rheumatology (Oxford, England)

Mamyrova G, McBride E, Yao L, Shrader JA, Jain M, Yao J, Curiel RV, Miller FW, Harris-Love MO, Rider LG.
PMID: 34791066
Rheumatology (Oxford). 2021 Nov 16; doi: 10.1093/rheumatology/keab833. Epub 2021 Nov 16.

OBJECTIVE: To compare muscle ultrasound (MUS) parameters in patients with juvenile dermatomyositis (JDM) and healthy controls, and examine their association with JDM disease activity measures and magnetic resonance imaging (MRI).METHODS: MUS of the right mid-rectus femoris was performed in...

Cite
Mamyrova G, McBride E, Yao L, et al. Preliminary Validation of Muscle Ultrasound in Juvenile Dermatomyositis (JDM). Rheumatology (Oxford). 2021;doi: 10.1093/rheumatology/keab833.
Mamyrova, G., McBride, E., Yao, L., Shrader, J. A., Jain, M., Yao, J., Curiel, R. V., Miller, F. W., Harris-Love, M. O., & Rider, L. G. (2021). Preliminary Validation of Muscle Ultrasound in Juvenile Dermatomyositis (JDM). Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/keab833
Mamyrova, Gulnara, et al. "Preliminary Validation of Muscle Ultrasound in Juvenile Dermatomyositis (JDM)." Rheumatology (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/rheumatology/keab833
Mamyrova G, McBride E, Yao L, Shrader JA, Jain M, Yao J, Curiel RV, Miller FW, Harris-Love MO, Rider LG. Preliminary Validation of Muscle Ultrasound in Juvenile Dermatomyositis (JDM). Rheumatology (Oxford). 2021 Nov 16; doi: 10.1093/rheumatology/keab833. Epub 2021 Nov 16. PMID: 34791066.
Copy Download .nbib Format: NLM
Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity.

Biochemical pharmacology

Muñoz M, López-Oliva E, Pinilla E, Rodríguez C, Martínez MP, Contreras C, Gómez A, Benedito S, Sáenz-Medina J, Rivera L, Prieto D.
PMID: 34822809
Biochem Pharmacol. 2022 Jan;195:114850. doi: 10.1016/j.bcp.2021.114850. Epub 2021 Nov 22.

Arachidonic acid (AA)-derived cytochrome P450 (CYP) derivatives, epoxyeicosatrienoic acids (EETs) and 20-hidroxyeicosatetranoic acid (20-HETE), play a key role in kidney tubular and vascular functions and blood pressure. Altered metabolism of CYP epoxygenases and CYP hydroxylases has differentially been involved...

Cite
Muñoz M, López-Oliva E, Pinilla E, et al. Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity. Biochem Pharmacol. 2021;195:114850doi: 10.1016/j.bcp.2021.114850.
Muñoz, M., López-Oliva, E., Pinilla, E., Rodríguez, C., Martínez, M. P., Contreras, C., Gómez, A., Benedito, S., Sáenz-Medina, J., Rivera, L., & Prieto, D. (2022). Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity. Biochemical pharmacology, 195114850. https://doi.org/10.1016/j.bcp.2021.114850
Muñoz, Mercedes, et al. "Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity." Biochemical pharmacology vol. 195 (2022): 114850. doi: https://doi.org/10.1016/j.bcp.2021.114850
Muñoz M, López-Oliva E, Pinilla E, Rodríguez C, Martínez MP, Contreras C, Gómez A, Benedito S, Sáenz-Medina J, Rivera L, Prieto D. Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity. Biochem Pharmacol. 2022 Jan;195:114850. doi: 10.1016/j.bcp.2021.114850. Epub 2021 Nov 22. PMID: 34822809.
Copy Download .nbib Format: NLM
Association of Anti-HSC70 Autoantibodies with Cutaneous Ulceration and Severe Disease in Juvenile Dermatomyositis.

Rheumatology (Oxford, England)

Karasawa R, Yudoh K, Sato T, Tanaka M, Tamaki M, Sabbagh SE, O'Hanlon TP, Noroozi-Farhadi P, Targoff IN, Flegel WA, Mammen AL, Miller FW, Hicar MD, Rider LG, Jarvis JN.
PMID: 34791087
Rheumatology (Oxford). 2021 Nov 13; doi: 10.1093/rheumatology/keab846. Epub 2021 Nov 13.

OBJECTIVES: Juvenile dermatomyositis (JDM) is an inflammatory myopathy characterized by prominent vasculopathy. Anti-endothelial cell antibodies (AECA) are frequently detected in inflammatory and autoimmune diseases. We sought to determine whether AECA correlate with clinical features of JDM, and thus serve...

Cite
Karasawa R, Yudoh K, Sato T, et al. Association of Anti-HSC70 Autoantibodies with Cutaneous Ulceration and Severe Disease in Juvenile Dermatomyositis. Rheumatology (Oxford). 2021;doi: 10.1093/rheumatology/keab846.
Karasawa, R., Yudoh, K., Sato, T., Tanaka, M., Tamaki, M., Sabbagh, S. E., O'Hanlon, T. P., Noroozi-Farhadi, P., Targoff, I. N., Flegel, W. A., Mammen, A. L., Miller, F. W., Hicar, M. D., Rider, L. G., & Jarvis, J. N. (2021). Association of Anti-HSC70 Autoantibodies with Cutaneous Ulceration and Severe Disease in Juvenile Dermatomyositis. Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/keab846
Karasawa, Rie, et al. "Association of Anti-HSC70 Autoantibodies with Cutaneous Ulceration and Severe Disease in Juvenile Dermatomyositis." Rheumatology (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/rheumatology/keab846
Karasawa R, Yudoh K, Sato T, Tanaka M, Tamaki M, Sabbagh SE, O'Hanlon TP, Noroozi-Farhadi P, Targoff IN, Flegel WA, Mammen AL, Miller FW, Hicar MD, Rider LG, Jarvis JN. Association of Anti-HSC70 Autoantibodies with Cutaneous Ulceration and Severe Disease in Juvenile Dermatomyositis. Rheumatology (Oxford). 2021 Nov 13; doi: 10.1093/rheumatology/keab846. Epub 2021 Nov 13. PMID: 34791087.
Copy Download .nbib Format: NLM
Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Rivera L, Biswal S, Sáez-Llorens X, Reynales H, López-Medina E, Borja-Tabora C, Bravo L, Sirivichayakul C, Kosalaraksa P, Martinez Vargas L, Yu D, Watanaveeradej V, Espinoza F, Dietze R, Fernando L, Wickramasinghe P, Duarte Moreira E, Fernando AD, Gunasekera D, Luz K, Venâncio da Cunha R, Rauscher M, Zent O, Liu M, Hoffman E, LeFevre I, Tricou V, Wallace D, Alera MT, Borkowski A.
PMID: 34606595
Clin Infect Dis. 2021 Oct 04; doi: 10.1093/cid/ciab864. Epub 2021 Oct 04.

BACKGROUND: Takeda's live attenuated tetravalent dengue vaccine candidate (TAK-003) is under evaluation in a long-term clinical trial across eight dengue-endemic countries. Previously, we have reported its efficacy and safety in both seronegative and seropositive participants and that its performance...

Cite
Rivera L, Biswal S, Sáez-Llorens X, et al. Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003). Clin Infect Dis. 2021;doi: 10.1093/cid/ciab864.
Rivera, L., Biswal, S., Sáez-Llorens, X., Reynales, H., López-Medina, E., Borja-Tabora, C., Bravo, L., Sirivichayakul, C., Kosalaraksa, P., Martinez Vargas, L., Yu, D., Watanaveeradej, V., Espinoza, F., Dietze, R., Fernando, L., Wickramasinghe, P., Duarte Moreira, E., Fernando, A. D., Gunasekera, D., Luz, K., Venâncio da Cunha, R., Rauscher, M., Zent, O., Liu, M., Hoffman, E., LeFevre, I., Tricou, V., Wallace, D., Alera, M. T., Borkowski, A. (2021). Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab864
Rivera, Luis, et al. "Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003)." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab864
Rivera L, Biswal S, Sáez-Llorens X, Reynales H, López-Medina E, Borja-Tabora C, Bravo L, Sirivichayakul C, Kosalaraksa P, Martinez Vargas L, Yu D, Watanaveeradej V, Espinoza F, Dietze R, Fernando L, Wickramasinghe P, Duarte Moreira E, Fernando AD, Gunasekera D, Luz K, Venâncio da Cunha R, Rauscher M, Zent O, Liu M, Hoffman E, LeFevre I, Tricou V, Wallace D, Alera MT, Borkowski A. Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003). Clin Infect Dis. 2021 Oct 04; doi: 10.1093/cid/ciab864. Epub 2021 Oct 04. PMID: 34606595.
Copy Download .nbib Format: NLM
XSEDE training: Achieving access and inclusion.

Akli L, Madrid M, Alameda J, Rivera L, Gordon SI.
UIID-AD: 4102
2016; doi: 10.1145/2949550.2949586.

An XSEDE strategic goal is to extend use of high-end digital services to new communities by preparing the current and next generation of scholars, researchers, and engineers in the use of advanced digital technologies via training, education, and outreach....

Cite
Akli L, Madrid M, Alameda J, et al. XSEDE training: Achieving access and inclusion. 2016;doi: 10.1145/2949550.2949586.
Akli, L., Madrid, M., Alameda, J., Rivera, L., & Gordon, S. I. (2016). XSEDE training: Achieving access and inclusion. . https://doi.org/10.1145/2949550.2949586
Akli, L, et al. "XSEDE training: Achieving access and inclusion." vol. (2016). doi: https://doi.org/10.1145/2949550.2949586
Akli L, Madrid M, Alameda J, Rivera L, Gordon SI. XSEDE training: Achieving access and inclusion. 2016; doi: 10.1145/2949550.2949586. UIID-AD: 4102.
Copy Download .nbib Format: NLM
Showing 145 to 156 of 156 entries